BROKER MOVES: NFLX upgraded at Piper Sandler, with AMZN downgraded at Wells

UPGRADES

• Alibaba (BABA) ADRs Upgraded to Outperform at Macquarie; PT USD 145


• Ally Financial (ALLY) Upgraded to Overweight at JPMorgan; PT USD 40


• Arcadium Lithium (ALTM) Upgraded to Sector Outperform at Scotiabank


• Campbell Soup (CPB) Upgraded to Outperform at Bernstein; PT USD 58


• Coty (COTY) Upgraded to Buy at Jefferies; PT USD 12


• Couchbase (BASE) Upgraded to Overweight at Barclays; PT USD 19


• Coupang (CPNG) Upgraded to Outperform at Bernstein; PT USD 30


• Dynatrace (DT) Upgraded to Overweight at Barclays; PT USD 64


• Elastic (ESTC) Upgraded to Overweight at Barclays; PT USD 95


• Frontline PLC (FRO) Upgraded to Buy at BTIG; PT USD 30


• Gilead (GILD) Upgraded to Overweight at Wells Fargo; PT USD 100


• Integra LifeSciences (IART) Upgraded to Neutral at BTIG


• Mohawk Industries (MHK) Upgraded to Equal-Weight at Wells Fargo; PT USD 160


• Netflix (NFLX) Upgraded to Overweight at Piper Sandler


• NXP Semi (NXPI) Upgraded to Buy at UBS; PT USD 285


• PDD (PDD) ADRs Upgraded to Outperform at Macquarie; PT USD 224


• Tyler Tech (TYL) Upgraded to Overweight at Barclays; PT USD 700


• Western Alliance (WAL) Upgraded to Buy at Deutsche Bank

DOWNGRADES

• Amazon (AMZN) Downgraded to Equal-Weight at Wells Fargo; PT USD 183


• American Express (AXP) Downgraded to Neutral at JPMorgan; PT USD 286


• Ametek (AME) Downgraded to Sell at TD Cowen; PT USD 158


• Celanese (CE) Downgraded to Sector Weight at KeyBanc


• Charles River (CRL) Downgraded to Inline at Evercore ISI


• Ciena (CIEN) Downgraded to Neutral at JPMorgan; PT USD 65


• Constellation Brands (STZ) Downgraded to Neutral at BofA


• Deckers Outdoor (DECK) Downgraded to Neutral at Seaport Global Securities


• DuPont de Nemours (DD) Downgraded to Underweight at Barclays; PT USD 84


• Garmin (GRMN) Downgraded to Underweight at Morgan Stanley; PT USD 139


• Halozyme (HALO) Downgraded to Equal-Weight at Wells Fargo; PT USD 62


• Hershey (HSY) Downgraded to Market Perform at Bernstein; PT USD 205


• Hershey (HSY) Downgraded to Neutral at UBS; PT USD 209


• Humana (HUM) Downgraded to Hold at TD Cowen; PT USD 261


• Humana (HUM) Downgraded to Hold at Jefferies; PT USD 253


• Immunocore (IMCR) ADRs Downgraded to Neutral at Guggenheim


• Intapp (INTA) Downgraded to Equal-Weight at Barclays; PT USD 44


• KB Home (KBH) Downgraded to Underweight at Wells Fargo; PT USD 83


• Lamb Weston (LW) Downgraded to Neutral at JPMorgan; PT USD 68


• Lennar (LEN) Downgraded to Equal-Weight at Wells Fargo; PT USD 190


• Mobileye (MBLY) Downgraded to Underweight at JPMorgan; PT USD 10


• Netflix (NFLX) Downgraded to Underweight at Barclays; PT USD 550


• Sherwin-Williams (SHW) Downgraded to Sector Weight at KeyBanc


• SITE Centers (SITC) Downgraded to Sector Weight at KeyBanc

INITIATIONS

• ARM Holdings (ARM) ADRs Initiated at Neutral at Haitong Intl; PT USD 129


• Celldex (CLDX) Initiated at Buy at Citi; PT USD 70


• Celsius Holdings (CELH) Initiated at Market Perform at CICC; PT USD 34


• Dave & Buster's (PLAY) Initiated at Hold at Benchmark


• DiaMedica (DMAC) Initiated at Buy at HC Wainwright; PT USD 7


• Immatics (IMTX) Initiated at Overweight at Piper Sandler


• MasTec (MTZ) Initiated at Overweight at JPMorgan; PT USD 153


• MKS Instruments (MKSI) Initiated at Outperform at Mizuho Securities


• Monster Beverage (MNST) Initiated at Market Perform at CICC; PT USD 58


• Oruka Therapeutics Inc (ORKA) Initiated at Buy at HC Wainwright; PT USD 45


• Primoris Services (PRIM) Initiated at Overweight at JPMorgan; PT USD 71


• Quanta Services (PWR) Initiated at Neutral at JPMorgan; PT USD 297


• Serve Robotics (SERV) Initiated at Buy at Seaport Global Securities


• Sila Realty Trust (SILA) Initiated at Buy at Truist Secs; PT USD 29


• Solventum (SOLV) Initiated at Neutral at Piper Sandler


• Toast (TOST) Initiated at Buy at William O'Neil


• Vertiv Holdings (VRT) Initiated at Buy at Jefferies; PT USD 125


• Westrock Coffee (WEST) Initiated at Buy at Truist Secs; PT USD 10


• Zevra Therapeutics Inc (ZVRA) Initiated at Buy at Guggenheim; PT USD 20

07 Oct 2024 - 12:07- Research Sheet- Source: Newswires